{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:13Z","timestamp":1786984333478,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ajog.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T23:17:48Z","timestamp":1491952668000},"page":"512-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Current and future role of genetic screening in\u00a0gynecologic malignancies"],"prefix":"10.1016","volume":"217","author":[{"given":"Kari L.","family":"Ring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Modesitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.04.011_bib1","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ajog.2017.04.011_bib2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2017.04.011_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","article-title":"Germline RAD51C mutations confer susceptibility to ovarian cancer","volume":"44","author":"Loveday","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2017.04.011_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2017.04.011_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib6","doi-asserted-by":"crossref","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2017.04.011_bib7","unstructured":"NCCN. Clinical practice guidelines in oncology: genetic\/familial high-risk assessment: colorectal. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed Oct. 11,\u00a02016."},{"key":"10.1016\/j.ajog.2017.04.011_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","article-title":"The clinical phenotype of Lynch syndrome due to germline PMS2 mutations","volume":"135","author":"Senter","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajog.2017.04.011_bib9","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2017.04.011_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cncr.26191","article-title":"Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer","volume":"118","author":"Stadler","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ajog.2017.04.011_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2017.04.011_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2017.04.011_bib16","unstructured":"SGO. Clinical practice statement: genetic testing for ovarian cancer. Available at: https:\/\/www.sgo.org\/clinical-practice\/guidelines\/genetic-testing-for-ovarian-cancer\/. Accessed Oct. 24,\u00a02016."},{"key":"10.1016\/j.ajog.2017.04.011_bib17","unstructured":"NCCN. Guidelines, genetic\/familial high-risk assessment: breast and ovarian. Version 1. 2017 2016. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed January 31, 2017."},{"key":"10.1016\/j.ajog.2017.04.011_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAP.0b013e3182a92cf8","article-title":"Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype","volume":"20","author":"Chui","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ajog.2017.04.011_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome\u2013associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2017.04.011_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/qjmed\/hcv137","article-title":"Lynch syndrome in the 21st century: clinical perspectives","volume":"109","author":"Tiwari","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.ajog.2017.04.011_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2011.03.024","article-title":"Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry","volume":"122","author":"Schultz","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajog.2017.04.011_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.dld.2012.12.018","article-title":"Cancer risk associated with STK11\/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study","volume":"45","author":"Resta","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajog.2017.04.011_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10689-015-9831-y","article-title":"Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry","volume":"15","author":"Schultz","year":"2016","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2012.01.049","article-title":"Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer \u226470 years","volume":"125","author":"Leenen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/GRF.0b013e3182185a41","article-title":"Lynch syndrome","volume":"54","author":"Backes","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2017.04.011_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2503","article-title":"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas","volume":"45","author":"Palles","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajog.2017.04.011_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10689-013-9615-1","article-title":"Cancer risk in Lynch syndrome","volume":"12","author":"Barrow","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib34","unstructured":"SGO. Clinical practice statement: screening for Lynch syndrome in endometrial cancer. Available at: https:\/\/www.sgo.org\/clinical-practice\/guidelines\/screening-for-lynch-syndrome-in-endometrial-cancer\/. Accessed Oct. 24,\u00a02016."},{"key":"10.1016\/j.ajog.2017.04.011_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.4185","article-title":"Germline and somatic polymerase \u03b5 and \u03b4 mutations define a new class of hypermutated colorectal and endometrial cancers","volume":"230","author":"Briggs","year":"2013","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2017.04.011_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gim.2015.75","article-title":"POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and\/or polyposis: review of reported cases and recommendations for genetic testing and surveillance","volume":"18","author":"Bellido","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2017.04.011_bib37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1572-0241.2000.01831.x","article-title":"Peutz-Jeghers syndrome","volume":"95","author":"McGarrity","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajog.2017.04.011_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/modpathol.2011.185","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations","volume":"25","author":"Dehner","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2017.04.011_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/pbc.24826","article-title":"DICER1 mutations in an adolescent with cervical embryonal rhabdomyosarcoma (cERMS)","volume":"61","author":"Tomiak","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib40","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ajog.2005.01.041","article-title":"The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer","volume":"192","author":"Fishman","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib41","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib42","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/AOG.0b013e31819cda77","article-title":"Results from four rounds of ovarian cancer screening in a randomized trial","volume":"113","author":"Partridge","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2008.05.006","article-title":"The\u00a0epidemiology of CA-125 in women without\u00a0evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian cancer (PLCO) screening trial","volume":"110","author":"Johnson","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib44","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1158\/1940-6207.CAPR-10-0402","article-title":"Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status","volume":"4","author":"Skates","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ajog.2017.04.011_bib45","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib46","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1200\/JCO.2005.05.097","article-title":"Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System","volume":"23","author":"Stirling","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib47","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1200\/JCO.2005.01.6642","article-title":"Prospective study using the Risk of Ovarian Cancer Algorithm to screen for ovarian cancer","volume":"23","author":"Menon","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ajog.2017.04.011_bib48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JCO.2003.02.955","article-title":"Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women","volume":"21","author":"Skates","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2016.02.020","article-title":"Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial","volume":"141","author":"Narod","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib50","doi-asserted-by":"crossref","unstructured":"Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. The Lancet. 387(10022):945-956.","DOI":"10.1016\/S0140-6736(15)01224-6"},{"key":"10.1016\/j.ajog.2017.04.011_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1200\/JCO.2011.39.7638","article-title":"Results of annual screening in phase I of the United Kingdom Familial Ovarian Cancer Screening Study highlight the need for strict adherence to screening schedule","volume":"31","author":"Rosenthal","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib52","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.69.9330","article-title":"Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom Familial Ovarian Cancer Screening Study","author":"Rosenthal","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A\u00a0prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2017.04.011_bib54","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-2750","article-title":"Early detection of ovarian cancer using the Risk of Ovarian Cancer Algorithm with frequent CA125 testing in women at increased familial risk\u2013combined results from two screening trials","author":"Skates","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2017.04.011_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"Helder-Woolderink","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib56","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.22446","article-title":"Surveillance for endometrial cancer in the hereditary nonpolyposis colorectal cancer syndrome","volume":"120","author":"Renkonen-Sinisalo","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10689-009-9252-x","article-title":"Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome","volume":"8","author":"Gerritzen","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib58","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/cncr.10380","article-title":"The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma","volume":"94","author":"Dove-Edwin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2017.04.011_bib59","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.21873\/anticanres.10987","article-title":"Mismatch repair polymorphisms as markers of breast cancer prevalence in the breast cancer family registry","volume":"36","author":"Kappil","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajog.2017.04.011_bib60","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2017.04.011_bib61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","article-title":"Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27,276 women with endometrial cancer from 36 epidemiological studies","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib62","first-page":"1","article-title":"Oral contraceptive use for the primary prevention of ovarian cancer","volume":"212","author":"Havrilesky","year":"2013","journal-title":"Evid Rep Technol Assess"},{"key":"10.1016\/j.ajog.2017.04.011_bib63","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: a systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2017.04.011_bib64","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus Depo-Provera for prevention of endometrial cancer in women with Lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ajog.2017.04.011_bib65","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.011_bib66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2017.04.011_bib67","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib69","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib70","doi-asserted-by":"crossref","first-page":"djv033","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2017.04.011_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2017.04.011_bib72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.011_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib76","unstructured":"ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/. Accessed Oct. 18, 2016."},{"key":"10.1016\/j.ajog.2017.04.011_bib77","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01.AOG.0000456325.50739.72","article-title":"Lynch syndrome. Practice bulletin No. 147","volume":"124","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.011_bib78","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib79","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/modpathol.2016.135","article-title":"Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort","volume":"29","author":"Ring","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2017.04.011_bib80","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.011_bib81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.04.011_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A\u00a0practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2017.04.011_bib83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817305124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817305124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:16:34Z","timestamp":1757589394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817305124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0002937817305124"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.04.011","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future role of genetic screening in\u00a0gynecologic malignancies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}